Reperfusion injury after intestinal ischemia: Pathophysiology and experimental models;Lesões intestinais decorrentes de isquemia e reperfusão: Fisiopatologia e modelos experimentais

Jornal Vascular Brasileiro

Volumn 4, Issue 2, 2005, Pages 183-194

  Ribeiro, Marcelo Eduardo ^a   Yoshida, Winston Bonetti ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Intestines; Ischemia; Reperfusion

Indexed keywords

ARTERY THROMBOSIS; DISEASE SEVERITY; EMBOLISM; EXPERIMENTAL MODEL; HUMAN; INTESTINE INJURY; INTESTINE ISCHEMIA; NONHUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; VASCULAR SURGERY;

EID: 23744472010     PISSN: 16775449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Simi AC. Isquemia intestinal. Maffei FHA. Doenças vasculares periféricas. Rio de Janeiro: MEDSI; 2002. p. 1239-57.
2. Boley SJ, Kraiger H, Schultz L, et al. Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynec Obstet. 1965;121:789-96.
3. Bergan JJ. Recognition of a treatment of intestinal ischemia. Surg Clin North Am 1967;47:109-14.
4. Jackson BB. Occlusion of superior mesenteric artery. Springfield: Charles C Thomas; 1963.
5. Ottinger LW, Austen WG. A study of 136 patients of mesenteric infartion. Surg Gynecol Obstet 1967;124:329-37.
6. Rosa SM, Kotze LMS. Doenças vasculares dos intestinos. In: Dani R, org. Gastroenterologia essencial. 2a ed. Rio de Janeiro: Guanabara Koogan; 2001. p. 300-314.
7. Britt LG, Cheek RC. Nonoclusive mesenteric vascular disease: clinical and experimental observations. Ann Surg 1969;169:704-11.
8. Moneta GL, Misbach GA, Ivey TD. Hypoperfusion as a possible factor in the development of gastrointestinal complications after cardiology surgery. Ann J Surg 1985;149:648-50.
9. Landrevean RJ, Fry WJ. The right colon as a target organ of nonoclusive mesenteric ischemia. Arch Surg 1990;125:591-4.
10. Greene FL, Ariyan S, Stansel HC Jr. Mesenteric and peripheral vascular ischemia secondary to ergotism. Surgery 1977;81:176-9.
11. Nalbandian H, Sheth N, Dietrich R, Georgiou J. Intestinal ischemia caused by cocaine ingestion. Report of two cases. Surgery 1985;97:374-6.
12. Stoney RJ, Cunninghan CG. Acute mesenteric ischemia. Surgery 1993;114:489-90.
13. Hansen HJ. Emergency revascularization of SMA acute intestinal ischemia caused by thrombosis. Acta Cir Scan 1980;502:131-42.
14. Singh RP, Lee SR, Shah RC. Acute mesenteric vascular occlusion: a review of thirty-two patients. Surgery 1975;78:613-23.
15. Ritz JP, Runkel N, Berger G, Buhr HJ. Prognostic factors in mesenteric infarct. Zentralbl Chir 1997;122:332-8.
16. Bergan JJ, Dean RD, Conn Jr J, Yao JT. Revascularization of mesenteric infarction. Ann Surg 1975;182:430-9.
17. Shaw RS, Maynard EP. Acute and chronic thrombosis of the mesenteric arteries associated with malabsorption. N Eng J Med 1958;258:874-8.
18. Pergontz S, Ericsson B, Hedner V. Thrombosis in the surgery mesenteric of portal veins: report of case treated with thrombectomy. Surgery 1974;76:286-92.
19. Mergenthaler FW, Harris MN. Superior mesenteric veins thrombosis complicating pancreatoduodenectomy: successful treatment by thrombectomy. Ann Surg 1968;167:106-22.
20. Naitove A, Waissmann RE. Primary mesenteric venous thrombosis. Ann Surg 1965;101:516-33.
21. Horton JW, Walker PB. Oxygen Radicals lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J Apyphysiol 1993;12:82-95.
22. Yoshida WB. Radicais livres na síndrome de isquemia e reperfusão. Cir Vasc Angiol 1996;12:82-95.
23. Schoenberg MH, Berger HG. Reperfusion injury after intestinal ischemia. Crit Care Med 1993;21:1376-86.
24. Haward TR, Brooks DL, Flynn TC, et al. Multiple organ disdunction after mesenteric artery revascularization. J Vasc Surg 1993;18:459-69.
25. Myers SL, Hernandez R. Oxygen free radical regulation of rat splanchnic blood flow. Surgery 1992;112:347-54.
26. Myers SL, Hernandez R. Leukotrien C4 regulation of splanchnic blood flow during ischemia. Am J Surg 1994;167:566-9.
27. Bitterman H, Aoki N. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion shock. Proc Soc Exp Biol Med 1988;188:265-71.
28. Parks DA, Bulkley GB, Granger N. Role of oxygen derived free radicals in digestive tract diseases. Surgery 1983;94:415-22.
29. Yoshida WB. Fisiopatologia da isquemia e reperfusão. In: Maffei FHA. Doenças vasculares periféricas. Rio de Janeiro: MEDSI; 2002. p. 253-8.
30. Parks DA, Granger DN. Xantine oxidase biochemistry distribution and physiology. Acta Physiol Scand Supp 1986;548:87-9.
31. Grace PA. Ischemia-reperfusion injury. Br J Surg 1994;81:637-47.
32. Welborn CR, Goldman G, Peterson JS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischemia-reperfusion on injury: central role of the neutroph. Br J Surg 1991;78:651-5.
33. Murphy ME, Kolvenbach R, Aleksis M, et al. Antioxidant depletion in aortic cross clamping ischemia: increase of the plasma alpha-tocopherylquinone/ alpha-tocopherol ratio free radical. Biol Med 1992;13:95-100.
34. Yoshikawa T, Yasuda M, Ueda T, et al. Vitamin E gastric mucosal injury induced by ischemia and reperfusion. Am J Clin Nutr 1991;53:S210-4.
35. Del Maestro RF. An approach to free radicals in medicine and biology. Acta Physiol Scand 1980;492:153-68.
36. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986;13:6749-53.
37. Chiu CJ, Mcardle HH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesions in low-flow states. Arch Surg 1970;101:478-83.
38. Porter JM, Ivatury RR, Azimuddin K, Swami R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am Surg 1999;65:478-83.
39. Montgomery A, Borgström A, Haglund U. Pancreatic proteases and intestinal mucosal injury after ischemia and reperfusion in the pig. Gastroenterology 1992;102:216-22.
40. Boros M, Kaszaki J, Bakó L, Nagy S. Studies on the relationship between xanthine oxidase and histamine release during intestinal ischemia-reperfusion. Circ Shock 1992;38:108-14.
41. Harward TR, Coe D, Souba WN, et al. Glutamine preserves but gluthatione levels during intestinal ischemia and reperfusion. J Surg Vasc 1994;56:351-5.
42. Clark ET, Gewertz BL. Intermittent ischemia potentiates intestinal reperfusion injury, J Vasc Surg 1991;13:601-6.
43. Kaçmaz M, Ozturk HS, Karaayvaz M, Guven C, Durak I. Enzymatic antioxidant defense mechanism in rat intestinal tissue is changed after ischemia-reperfusion. Effects of an allopurunol plus antioxidant combination. Can J Surg 1999;42:427-31.
44. Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP, FCCM. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 2001;29:1513-18.
45. Aldemir M, Ozturk H, Guloglu C, Buyukbayram H. Effects of in vivo freezing and manitol in intestinal ischemia-reperfusion injury. Injury 2003;34:173-9.
46. Fujino Y, Sussuki Y, Kakiniki K, Ku Y, Kuroda Y. Protection against experimental small intestinal ischemia-reperfusion injury with oxigenated perfluochemical. Br J Surg 2003;90:1015-20.
47. Montero EF, Abrahao MS, Koike MK, Manna MC, Ramalho CE. Intestinal ischemia and reperfusion and N-acetycysteine modulation. Microsurgery 2003;23:517-21.
48. Biondo-Simões MLP, Greca FH, Ioshi S, Tawil IIE, Menini CM, Rampazzo JC. Influência do antibiótico nas lesões de isquemia e reperfusão intestinal, estudo experimental em ratos. Acta Cir Bras 2000;15:83-7.
49. Brito MVH, Araújo M, Acácio GJS, Reis JMC. Lesão intestinal após isquemia-reperfusão: estudo comparativo usando sal tetrazólico (MTT) e histologia. Acta Cir Bras 2001;16:26-31.
50. Aoki N, Siegfried M, Tsao P, Lento P, Leger A. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock. Chem Pathol Pharm 1988;60:775-89.
51. Simonian GT, Dardik H, Hallac D, Ibrahim J, Stahl R. Pharmacologic amelioration of splanchnic arterial occlusion shock and reperfusion injury: comparative studies of microvascular permeability and free radical toxicity in a rat model. Vasc Surg 1997;31:645-56.
52. Yoshida WB, Alasio T, Maziotta R, Qin F, Kashani M, Lee S, Dardik H. Effect of alpha-tocopherol, taurine and selenium in the attenuation of the injuries of ischemia and reperfusion in splanchnic organs. Cardiovasc Surg 1998;6:178-87.
53. Cuzzocrea S, Misko TP, Constantino G, et al. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. Faseb J 2000;14:1061-72.
54. Mazzon E, Dugo L, De AS, Li JH, Caput AP, Zahang J, Cruzzocrea S. Beneficial effects of GPI 6150, an inhibitor of poly (ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 2002;17:222-7.
55. Cuzzocrea S, McDonald MC, Mazzon E, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock 2000;14:150-6.
56. Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone and 15-deoxy-{delta} 12,14-prostagalndin J2, ligar of the peroxisome proliferator-activated receptor-{gama} (PPA {gama}), reduce ischemia/reperfusion injury of the gut. Br J Pharmacol 2003;140:366-76.
57. Macarenco RSS, Takagi RU, Bardella LC, Sequeira JL, Yoshida WB. Estudo da ação do extrato de Gingko biloba e amido hidroxietílico na atenuação de alterações decorrentes de isquemia e reperfusão de orgãos esplâncnicos em ratos. Acta Cir Bras 2001;16:26-31.
58. Deune EG, Khouri RK. Rat strain differences in flap tolerance to ischemia. Microsurgery 1995;16:765-7.
59. Kirschner RE, Fantini GA. Role of iron oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Surg 1994;179:103-17.
60. Haglind E, Xia G, Rylander R. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat. Circ Shock 1994;42:83-91.
61. Lelli JL, Pradhan S, Cobb M. Prevention of post-ischemic injury in immature intestine by desferoxamine. J Surg Res 1993;54:34-8.
62. Moreno JB, Francischetti I, Hafner L. Lesões de isquemiareperfusão em músculos esqueléticos: fisiopatologia e novas tendências de tratamento, com ênfase em reperfusão controlada. J Vasc Br 2002;1:113-20.
63. Hinder RA, Stein HJ. Oxygen derived free radicals. Arch Surg 1991;126:104-5.
64. Nejima J, Knight DR, Fallon JT. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989;79:143-53.
65. Richard VJ, Murray CE, Jennings RB, Reiner KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation 1988;78:473-80.
66. Moreno JB. Efeito do alfa-tocoferol na atenuação da lesão de isquemia-reperfusão em membro posterior do rato [dissertação]. Botucatu: Faculdade de Medicina de Botucatu, UNESP; 1991.
67. Canfield LM, Forage JW, Valenzuela JG. Carotenoides as cellular antioxidants. Proc Soc Exp Biol Med 1992;200:260-6.
68. Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992;26:641-55.
69. Levander AO. Selenium and sulfur in antioxidant protective systems: relationship with vitamin E and malaria. Proc Soc Exp Biol Med 1992;200:255-9.
70. Hoekstra WG. Biochemical function of selenium and its relation to vitamin E. Fed Proc 1975;34:2083-9.
71. Freeman BA, Crapo JD. Biology of disease, free radicals and tissue injury. Lab Invest 1982;47:412-26.
72. Paterson IS, Klausner JM, Goldman G, et al. Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg 1988;210:796-801.
73. Pó JF. Isquemia e reperfusão na oclusão aórtica em cães. Alterações hemodinâmicas, ação de radicais livres e lesões estruturais [dissertação]. São Paulo: Universidade Federal de São Paulo; 1995.
74. Ambrosio G, Zweier J, Jacoubs WE, Weisfelot ML, Flaherty JT. Improvement of postischaemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76:906-15.
75. Badylak SF, Simons A, Turek J, Babos CF. Protection from reperfusion injury in the isolated heart by deferoxamine and allopurinol administration. Cardiovac Res 1987;21:500-6.
76. Sardinha WE. Isquemia e reperfusão da musculatura esquelética em ratos. Inibição das lesões lipoperoxidativas mediadas por radicais livres pela desferoxamina [tese]. São Paulo: Escola Paulista de Medicina; 1994.
77. Menasche P, Pasquier C, Belluci S. Deferoxamine reduces neutrophyl mediated free radical production during cardiopulmonary by pass in man. J Thorac Cardiovasc Surg 1988;96:582-9.
78. Hedlund BE, Hallaway PE, Mahoney JR. High molecular weight forms of deferoxamine: novel therapeutic agents for treatment of iron mediated tissue injury. Adv Exp Med Biol 1990;264:229-34.
79. Granger DN, Kvietys PR, Perry MO. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can J Phisiol Pharmacol 1993;71:67-75.
80. Romson JL, Hook BG, Kunkel SL, Abrams GO, Schorek MA, Lucchesi BR. Reduction in the extent of ischemic myocardial injury by neutrophyl depletion in the dog. Circulation 1983;67:1016-23.
81. Cuzzocrea S, McDonald MC, Mazzon E, enefical effects of tempol, a membrane-permeale radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion. Shock 2000;14:150-6.
82. Santos CHM, Gomes OM, Pontes JCDV, Miiji LNO, Higa EI. Uso de propofol (2,6 diisopropilfenol) como inibidor da lesão tecidual na isquemia e reperfusão mesentérica. Estudo experimental em ratos. Acta Cir Bras 2003;18.
83. Rangan U, Bulkley GB. Prospects for treatment of free radical-mediated tissue injury. Br Med Bull 1993;49:700-18.
84. Clark ET, Gewertz BL. Glucagon potentiates intestinal reperfusion injury. J Vasc Surg 1990;11:270-9.